QC
CNTB

Quadrature Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Quadrature Capital’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
+42,303
New +$103K ﹤0.01% 1464

Other funds holding CNTB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Quadrature Capital's CNTB Position: Q2 2026 in Review

Quadrature Capital opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 42,303 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #1464 among its holdings.

16 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Quadrature Capital held 42,303 shares of Connect Biopharma Holdings worth $101K as of Q2 2026.
  • Connect Biopharma Holdings was a new Quadrature Capital position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1464 holding.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.